Sixty-three patients (62.4%) with MetS had lower serum adiponectin (P < 0.001) and HDL-C (P = 0.002) levels, higher serum TG (P < 0.001), fasting glucose (P < 0.001), CRP (P < 0.001), insulin (P = 0.004) levels, elevated BW (P < 0.001), WC (P < 0.001), BMI (P < 0.001), left and right-baPWV (P < 0.001), SBP (P = 0.014), HOMA1-IR (P = 0.001), HOMA2-IR (P = 0.002) values, and higher percentages of type 2 DM (P = 0.039) than those in the non-MetS group. The gene discussed is INS; the disease is metabolic syndrome.